Hepatocellular carcinoma risk in HBeAg-negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohort-Reference-Cited by-同舟云学术

Hepatocellular carcinoma risk in HBeAg-negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohort

Published:2014-07-15 Issue:2 Volume:22 Page:120-127
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Papatheodoridis G. V.¹,Manolakopoulos S.²,Touloumi G.³,Nikolopoulou G.⁴,Raptopoulou-Gigi M.⁵,Gogos C.⁶,Vafiadis-Zouboulis I.¹,Karamanolis D.⁷,Chouta A.⁸,Ilias A.⁹,Drakoulis C.¹⁰,Mimidis K.¹¹,Ketikoglou I.¹²,Manesis E.¹³,Mela M.¹⁴,Hatzis G.¹⁵,Dalekos G. N.¹⁶,

Affiliation:

1. Gastroenterology Department; Athens University Medical School; Laikon General Hospital of Athens; Athens Attica Greece

2. 2nd Department of Internal Medicine; Athens University Medical School; Hippokration General Hospital of Athens; Athens Attica Greece

3. Department of Hygiene; Epidemiology & Medical Statistics; Athens University Medical School; Athens Attica Greece

4. Viral Hepatitis Committee; KEELPNO; Athens Attica Greece

5. 2nd Medical Department; Aristotle University of Thessaloniki; Thessaloniki Greece

6. Department of Internal Medicine; University of Patras; Rio Achaia Greece

7. 2nd Gastroenterology Department; Evangelismos General Hospital of Athens; Athens Attiki Greece

8. 4th Department of Internal Medicine; Athens University Medical School; Athens Attica Greece

9. Gastroenterology Department; Papanikolaou General Hospital of Thessaloniki; Thessaloniki Greece

10. 2nd Department of Internal Medicine; General Hospital of Piraeus; Athens Greece

11. 1st Department of Internal Medicine; Democritus University of Thrace; Avdira Greece

12. Department of Internal Medicine; Hippokration General Hospital of Athens; Athens Greece

13. Division of Internal Medicine; Athens University Medical School; Athens Attica Greece

14. Gastroenterology Department; Polykliniki Hospital of Athens; Athens Greece

15. Department of Pathophysiology; Athens University Medical School; Athens Attica Greece

16. Department of Medicine & Research Laboratory of Internal Medicine; Thessaly University Medical School; Larissa Greece

Funder

Hellenic Center for Disease Control and Prevention

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12283/fullpdf

Reference23 articles.

1. Therapeutic strategies in the management of patients with chronic hepatitis B;Papatheodoridis;Lancet Infect Dis,2008

2. EASL Clinical Practice Guidelines: management of chronic hepatitis B virus infection;European Association for the Study of the Liver;J Hepatol,2012

3. Why do I treat HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues?;Papatheodoridis;Liver Int,2013

4. Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review;Papatheodoridis;J Hepatol,2010

5. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study;Papatheodoridis;Gut,2011

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Letter to the Editor: Benefits of stopping therapy in patients with cirrhotic hepatitis B, true effect or residual confounding?;Hepatology;2023-10-20

2. Evaluation of Depression, Anxiety and HealthRelated Quality of Life in Patients with Hepatitis B Virus-Infection;Flora the Journal of Infectious Diseases and Clinical Microbiology;2023-06-01

3. Health inequalities in the management of chronic hepatitis B virus infection in patients from sub-Saharan Africa in high-income countries;JHEP Reports;2023-02

4. Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment;World Journal of Gastroenterology;2022-06-07

5. Impact of modern antiviral therapy of chronic hepatitis B and C on clinical outcomes of liver disease;World Journal of Gastroenterology;2021-08-07